New research suggests that the drug Metformin, which is commonly prescribed for patients with Type 2 diabetes, is associated with increased risks for low levels of thyroid-stimulating hormone for those with underactive thyroid.
New research suggests that the drug Metformin, which is commonly prescribed for patients with Type 2 diabetes, is associated with increased risks for low levels of thyroid-stimulating hormone for those with underactive thyroid.
Share this Article
Recommended